(Q34882653)

5 August 2017

1 reference

title

Molecular mechanisms of inherited cardiomyopathies (English)

1 reference

5 August 2017

Diane Fatkin

1

1 reference

5 August 2017

Robert M Graham

series ordinal

2

1 reference

5 August 2017

publication date

1 October 2002

1 reference

5 August 2017

published in

Physiological Reviews

1 reference

5 August 2017

volume

82

1 reference

5 August 2017

issue

4

1 reference

5 August 2017

page(s)

945-980

1 reference

Localization of a gene responsible for arrhythmogenic right ventricular dysplasia to chromosome 3p23.

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Prevalence and characteristics of dystrophin defects in adult male patients with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Hypertrophic cardiomyopathy associated with tacrolimus in paediatric transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Calcium fluxes involved in control of cardiac myocyte contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Effects of two hypertrophic cardiomyopathy mutations in alpha-tropomyosin, Asp175Asn and Glu180Gly, on Ca2+ regulation of thin filament motility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

A novel X-linked gene, G4.5. is responsible for Barth syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Altered crossbridge kinetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Neonatal, lethal noncompaction of the left ventricular myocardium is allelic with Barth syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

A Mutant Tropomyosin That Causes Hypertrophic Cardiomyopathy Is Expressed In Vivo and Associated With an Increased Calcium Sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Gene mapping of familial autosomal dominant dilated cardiomyopathy to chromosome 10q21-23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

A receptor-mediated pathway for cholesterol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Cytosine methylation confers instability on the cardiac troponin T gene in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Idiopathic Dilated Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Localization of a gene responsible for familial dilated cardiomyopathy to chromosome 1q32.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the alpha cardiac myosin heavy chain gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Association of nonsense mutation of dystrophin gene with disruption of sarcoglycan complex in X-linked dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Altered cardiac excitation-contraction coupling in mutant mice with familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

A mouse model of familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Mutations in the LMNA gene encoding lamin A/C

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Missense mutations in desmin associated with familial cardiac and skeletal myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Identification of a gene responsible for familial Wolff-Parkinson-White syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Mutations in beta-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin-binding protein-C

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Frequency and phenotypes of familial dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Increased expression of cytoskeletal, linkage, and extracellular proteins in failing human myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Homozygous mutation in cardiac troponin T: implications for hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

First mutation in cardiac troponin C, L29Q, in a patient with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

The structural basis of muscle contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Mechanics and models of the myosin motor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

The mechanism of muscular contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Apoptosis as a possible cause of gradual development of complete heart block and fatal arrhythmias associated with absence of the AV node, sinus node, and internodal pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Investigation of a family with autosomal dominant dilated cardiomyopathy defines a novel locus on chromosome 2q14-q22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Familial dilated cardiomyopathy in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Myosin binding protein C, a phosphorylation-dependent force regulator in muscle that controls the attachment of myosin heads by its interaction with myosin S2

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Restrictive Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

The locus of a novel gene responsible for arrhythmogenic right-ventricular dysplasia characterized by early onset and high penetrance maps to chromosome 10p12-p14.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Desmin mutation responsible for idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Altered cardiac troponin T in vitro function in the presence of a mutation implicated in familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Mechanism of adenosine triphosphate hydrolysis by actomyosin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Dilated cardiomyopathy associated with deficiency of the cytoskeletal protein metavinculin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Expression of a mutation causing hypertrophic cardiomyopathy disrupts sarcomere assembly in adult feline cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Expression of a mutant (Arg92Gln) human cardiac troponin T, known to cause hypertrophic cardiomyopathy, impairs adult cardiac myocyte contractility

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Mitochondrial cardiomyopathy: molecular and biochemical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Cardiac and skeletal actin gene mutations are not a common cause of dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Ryanodine receptor mutations in malignant hyperthermia and central core disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Linkage of familial dilated cardiomyopathy with conduction defect and muscular dystrophy to chromosome 6q23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

The Frequency of Familial Dilated Cardiomyopathy in a Series of Patients with Idiopathic Dilated Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Disruption of muscle architecture and myocardial degeneration in mice lacking desmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

A calcineurin-dependent transcriptional pathway for cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Sudden death due to troponin T mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Ca(2+)-desensitizing effect of a deletion mutation Delta K210 in cardiac troponin T that causes familial dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Marker chromosome 21 identified by microdissection and FISH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

A mutation in the dystrophin gene selectively affecting dystrophin expression in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Identification of the Syrian hamster cardiomyopathy gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Dominant-negative effect of a mutant cardiac troponin T on cardiac structure and function in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Prevention of cardiac hypertrophy by calcineurin inhibition: hope or hype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Metavinculin mutations alter actin interaction in dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Mapping a cardiomyopathy locus to chromosome 3p22-p25.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Actin mutations in dilated cardiomyopathy, a heritable form of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23-q24

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

A new locus for arrhythmogenic right ventricular cardiomyopathy (ARVD2) maps to chromosome 1q42-q43

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Structure of the actin-myosin complex and its implications for muscle contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Investigation of a truncated cardiac troponin T that causes familial hypertrophic cardiomyopathy: Ca(2+) regulatory properties of reconstituted thin filaments depend on the ratio of mutant to wild-type protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization Of cardiac transcript and protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Identification of a contractile deficit in adult cardiac myocytes expressing hypertrophic cardiomyopathy-associated mutant troponin T proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Functional analysis of the mutations in the human cardiac beta-myosin that are responsible for familial hypertrophic cardiomyopathy. Implication for the clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Dilated cardiomyopathy and sensorineural hearing loss: a heritable syndrome that maps to 6q23-24.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

A new locus for arrhythmogenic right ventricular dysplasia on the long arm of chromosome 14.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

LMNA, encoding lamin A/C, is mutated in partial lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Familial dilated cardiomyopathy locus maps to chromosome 2q31.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Altered interactions among thin filament proteins modulate cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Nuclear lamins: their structure, assembly, and interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Signaling in myocardial hypertrophy: life after calcineurin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: insights into disease pathogenesis and troponin function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

A new locus for autosomal dominant dilated cardiomyopathy identified on chromosome 6q12-q16

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Epidemiology of desmin and cardiac actin gene mutations in a european population of dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Contractile protein mutations and heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy. Evidence for a dominant negative action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Relation between crossbridge structure and actomyosin ATPase activity in rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Single-motor mechanics and models of the myosin motor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Decreased expression of the cardiac LIM domain protein MLP in chronic human heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Evidence of Apoptosis in Arrhythmogenic Right Ventricular Dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

Homozygotes for a R869G Mutation in the β -myosin Heavy Chain Gene have a Severe Form of Familial Hypertrophic Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00012.2002

10.1152/PHYSREV.00012.2002

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference